ArticleBritish journal of clinical pharmacology2012

Authors' response to Hermann et al. Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of marketed products from RCTs.

Koenraad Blot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.